Thakur, A.; Moyo, P.; van der Westhuizen, C.J.; Yang, H.O.; Maharaj, V.
A Novel Cardenolide Glycoside Isolated from Xysmalobium undulatum Reduces Levels of the Alzheimer’s Disease-Associated β-Amyloid Peptides Aβ42 In Vitro. Pharmaceuticals 2021, 14, 743.
https://doi.org/10.3390/ph14080743
AMA Style
Thakur A, Moyo P, van der Westhuizen CJ, Yang HO, Maharaj V.
A Novel Cardenolide Glycoside Isolated from Xysmalobium undulatum Reduces Levels of the Alzheimer’s Disease-Associated β-Amyloid Peptides Aβ42 In Vitro. Pharmaceuticals. 2021; 14(8):743.
https://doi.org/10.3390/ph14080743
Chicago/Turabian Style
Thakur, Anuradha, Phanankosi Moyo, Carl Johan van der Westhuizen, Hyun Ok Yang, and Vinesh Maharaj.
2021. "A Novel Cardenolide Glycoside Isolated from Xysmalobium undulatum Reduces Levels of the Alzheimer’s Disease-Associated β-Amyloid Peptides Aβ42 In Vitro" Pharmaceuticals 14, no. 8: 743.
https://doi.org/10.3390/ph14080743
APA Style
Thakur, A., Moyo, P., van der Westhuizen, C. J., Yang, H. O., & Maharaj, V.
(2021). A Novel Cardenolide Glycoside Isolated from Xysmalobium undulatum Reduces Levels of the Alzheimer’s Disease-Associated β-Amyloid Peptides Aβ42 In Vitro. Pharmaceuticals, 14(8), 743.
https://doi.org/10.3390/ph14080743